Clinical Trials for Julie Means-Powell

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentECOGBRES1207
10/31/2013
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e3 Breast Cancer Study- evaluating everolimus with endocrine therapy.
TreatmentVICCPHI1333
09/18/2013
A Phase I Dose Escalation Open-Label Safety, Pharmacokinetic and Pharmacodynamic Study to Determine the Recommended Phase II Dose of GSK1120212 Dosed in Combination with GSK2141795

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.